Article Details
Retrieved on: 2025-04-27 16:08:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
We have learned that daratumumab or isatuximab [or other] monoclonal CD38 antibodies added to these induction therapies are critical in the right ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here